NCT00033215View on ClinicalTrials.gov

A Phase 1 Study of S-3304 in Patients With Solid Tumors

PHASE1CompletedINTERVENTIONAL

Enrollment

32

Participants

Timeline

Start Date

November 30, 2001

Primary Completion Date

February 13, 2003

Study Completion Date

March 12, 2003

Conditions

Solid Tumors

Interventions

DRUG

S-3304

Trial Locations (4)

14263

Roswell Park Cancer Center, Buffalo

33612

H. Lee Moffitt Concer Center and Research Institute, Tampa

44195

Cleveland Clinic Foundation, Cleveland

80262

University of Colorado Hospital, Denver

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Shionogi

INDUSTRY